๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Metastatic Triple-negative Breast Cancer

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs NCT06908928Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Aurora Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: bulumtatug fuvedotin, bulumtatug fuvedotin The Clinical Study of the Efficacy and Safety of Trop2-ADC Monotherapy or Combination Immunotherapy Strategy in the Treatment of Advanced Triple-negative Breast Cancer. NCT06851299Phase 21 site๐Ÿ“ Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ยท Tests: trop2-ADC, ADC +anti-angiogenic drug, ADC + PD1 monoclonal antibody +anti-angiogenic drug Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients NCT06962163NA1 site๐Ÿ“ Saint-Herblain Institut Cancerologie de l'Ouest ยท Tests: [68Ga]Ga-PentixaFor PET/CT A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors NCT07318805Phase 113 sites๐Ÿ“ Duarte๐Ÿ“ Grand Rapids๐Ÿ“ Long Island City Pfizer ยท Tests: PF-08032562, Fulvestrant, Cetuximab, Fluorouracil, Oxaliplatin The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) ๏ผšSingle-arm, Prospective, Open Clinical Study NCT06125080Phase 21 site๐Ÿ“ Wuhan Huihua Xiong ยท Tests: Utidelone, Tirelizumab, Bevacizumab DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs NCT06176261Phase 23 sites๐Ÿ“ Miami๐Ÿ“ Boston๐Ÿ“ Durham Nancy Lin, MD ยท Tests: Datopotamab Deruxtecan A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer NCT06508216Phase 1, Phase 21 site๐Ÿ“ Villejuif Gustave Roussy, Cancer Campus, Grand Paris ยท Tests: Dato-DXd, Durvalumab Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors NCT05969041Phase 16 sites๐Ÿ“ Darlinghurst๐Ÿ“ Randwick๐Ÿ“ Westmead Myeloid Therapeutics ยท Tests: MT-302 (A) Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC) NCT05660083Phase 23 sites๐Ÿ“ Bethesda๐Ÿ“ Houston๐Ÿ“ Houston The Methodist Hospital Research Institute ยท Tests: L-NMMA High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer NCT06492759Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: Radiation Therapy, Pembrolizumab, Nab-paclitaxel, Paclitaxel, Carboplatin Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer NCT06954480Phase 22 sites๐Ÿ“ London๐Ÿ“ London Queen Mary University of London ยท Tests: Datopotamab Deruxtecan (Dato-DXd), Durvalumab Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer NCT03606967Phase 230 sites๐Ÿ“ Orange๐Ÿ“ Sacramento๐Ÿ“ Aurora National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Carboplatin, Computed Tomography, Durvalumab 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors NCT06305962EARLY Phase 15 sites๐Ÿ“ Kingswood๐Ÿ“ Wollongong๐Ÿ“ Southport Radiopharm Theranostics, Ltd ยท Tests: 177Lu-RAD204 Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer NCT06434064Phase 21 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Echocardiography, Magnetic Resonance Imaging MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer NCT06247449NA1 site๐Ÿ“ Toronto Sunnybrook Health Sciences Centre ยท Tests: Brain imaging, Analysis of circulating tumor DNA, Testing Morbidities Index Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers NCT05296564Phase 1, Phase 21 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide, HBI 0201-ESO TCRT, Aldesleukin Seviteronel in Combination With Chemotherapy in Androgen-receptor Positive Metastatic Triple-negative Breast Cancer NCT04947189Phase 1, Phase 21 site๐Ÿ“ Darlinghurst St Vincent's Hospital, Sydney ยท Tests: Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer NCT06774027n/a3 sites๐Ÿ“ San Francisco๐Ÿ“ The Bronx๐Ÿ“ Durham University of California, San Francisco ยท Tests: Specimen collection, Non-Investigational Antibody-Drug Conjugates (ADC), Medical Record Review The TASTY-steering Study NCT07258563NA11 sites๐Ÿ“ Amsterdam๐Ÿ“ Arnhem๐Ÿ“ Dirksland University Medical Center Groningen ยท Tests: Taste steering Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC NCT04265872EARLY Phase 11 site๐Ÿ“ Dallas Baylor Research Institute ยท Tests: Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients NCT03671044Phase 34 sites๐Ÿ“ Columbus๐Ÿ“ Springfield๐Ÿ“ Canton Jina Pharmaceuticals Inc. ยท Tests: Nanosomal Docetaxel Lipid Suspension (75 mg/m2), Nanosomal Docetaxel Lipid Suspension (100 mg/m2), Taxotereยฎ (100 mg/m2) Imaging Study in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC NCT07671092EARLY Phase 16 sites๐Ÿ“ St Leonards๐Ÿ“ Nedlands๐Ÿ“ Perth RayzeBio, Inc. ยท Tests: RYZ211/212 Granzyme B-PET: Predicting Immunotherapy Efficacy in TNBC NCT07705438n/a1 site๐Ÿ“ Shanghai Fudan University ยท Tests: [68Ga]Ga-DOTA-GSI PET/CT (Granzyme B PET/CT) Nuvastaticยฎ Phase III Trial for Fatigue in Triple-Negative Breast Cancer NCT07669467Phase 36 sites๐Ÿ“ Visakhapatnam๐Ÿ“ Mysore๐Ÿ“ Jalgaon Natureceuticals Sdn Bhd ยท Tests: Nuvastatic 300, Placebo A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites๐Ÿ“ Denver๐Ÿ“ Sarasota๐Ÿ“ Detroit IDEAYA Biosciences ยท Tests: IDE034 Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) NCT06189209Phase 29 sites๐Ÿ“ Vijayawada๐Ÿ“ Bangalore๐Ÿ“ Mumbai Rhizen Pharmaceuticals SA ยท Tests: Tenalisib Induction Therapy of PTX+BV Followed by Atezolizumab+Nab-PTX for PD-L1+ TNBC NCT06793553Phase 21 site๐Ÿ“ Koto-ku, 3-8-31 Japan Breast Cancer Research Group ยท Tests: Induction therapy Atezolizumab and Chemotherapy Treatment as T-cell Activators in Metastatic Triple Negative Breast Cancer Patients NCT06690840Phase 25 sites๐Ÿ“ Monza๐Ÿ“ Roma๐Ÿ“ Roma European Institute of Oncology ยท Tests: Atezolizumab in combination with Cyclophosphamide and Vinorelbine A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors NCT07229313Phase 17 sites๐Ÿ“ Santa Monica๐Ÿ“ New Have๐Ÿ“ Camperdown Kivu Bioscience Inc. ยท Tests: KIVU-107
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy